Literature DB >> 10418891

Multiple sclerosis and hepatitis B vaccine?

A Hall1, M Kane, C Roure, A Meheus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10418891     DOI： 10.1016/s0264-410x(99)00066-3

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  5 in total

1.  Recurrent skin peeling following Kawasaki disease.

Authors:  C Michie; V Kinsler; R Tulloh; S Davidson
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

Review 2.  [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Authors:  M Löbermann; B Handorn; A Winkelmann; E C Reisinger; H P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

3.  ADVANCE: The promises, pitfalls, and future prospects of a European distributed data network for immunization surveillance and research.

Authors:  Frank DeStefano; Robert T Chen; Hector S Izurieta; June M Raine
Journal:  Vaccine       Date:  2020-12-22       Impact factor: 3.641

4.  Low Coverage of Hepatitis B Vaccine and Determinants Among Health Professionals Working in Amhara Regional State Hospitals, Ethiopia.

Authors:  Berhanu Elfu Feleke
Journal:  J Public Health Afr       Date:  2016-12-31

Review 5.  Sustaining Vaccine Confidence in the 21st Century.

Authors:  Karin Hardt; Ruprecht Schmidt-Ott; Steffen Glismann; Richard A Adegbola; François P Meurice
Journal:  Vaccines (Basel)       Date:  2013-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.